Navigation Links
Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
Date:2/26/2008

l development of talactoferrin as a single agent in patients with NSCLC who have failed two or more previous therapies. In addition, favorable Scientific Advice was received from the European Medicines Agency (EMEA) indicating that the planned single pivotal Phase 3 global trial with talactoferrin monotherapy in patients who have failed two or more previous therapies can also support a Marketing Authorization Application (MAA) in the European Union.

Final Phase 2 Study Results

The Phase 2 trial was a double-blind, placebo-controlled, single-agent study evaluating the safety and activity of oral talactoferrin monotherapy in 100 patients with stage IIIB/IV NSCLC whose cancer had progressed after previous chemotherapy. Patients received standard supportive care and were randomly assigned to receive either oral talactoferrin (1.5 g; n=47) or placebo (n=53) twice a day. Patients did not receive any other anti-cancer therapy while on the trial. Treatment was administered in 14-week cycles (12 weeks on, two weeks off) for up to three cycles or until disease progression. All 100 patients were included in the intent-to-treat (ITT) population. The 81 patients who had at least one CT scan after initiating treatment were prospectively defined as the evaluable population. The primary endpoint was overall survival in the 100-patient ITT population.

The study met its pre-specified primary endpoint - improvement in overall survival. In the 100-patient ITT population, median overall survival was 65% higher in the talactoferrin group compared to the placebo group - 6.1 months versus 3.7 months (hazard ratio=0.68; p=0.0404). In the 81-patient prospectively-defined evaluable population, the median overall survival was 80% higher in the talactoferrin group compared to the placebo group - 7.9 months versus 4.4 months (hazard ratio=0.59; p=0.0171). The six-month survival rate in the ITT population was also significantly better in the talactoferrin group (49%) compared
'/>"/>

SOURCE Agennix
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
2. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
3. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
4. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
5. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
6. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
7. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
8. Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior
9. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
10. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
11. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015   Temptime Corporation , the ... care industry, announced today that its board of directors ... to chief executive officer.  Mr. Van den Hooff ... 2011. "Renaat deeply values Temptime,s mission of ... of expanding Temptime,s products and services to organizations that ...
(Date:5/5/2015)... --  InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the ... it will release its full financial results for the first ... before the open, followed by a conference call at ... outlook. Participants should call (888) 243-4451 ( ... the InspireMD call. A live webcast of the call will ...
(Date:5/5/2015)... LINCOLNSHIRE, Ill. , May 5, 2015 /PRNewswire/ ... medical diagnostic testing equipment and information systems technology, ... laboratory information systems company. This partnership allows Sysmex ... software and interfacing solution for physician offices and ... analyzer directly to Electronic Medical Record (EMR) systems. ...
Breaking Medicine Technology:Temptime President Renaat Van den Hooff Promoted to CEO 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 3
... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... the appointment of Mr. Kenneth Lee as a director to ... to replace Mr. Xianping Wang who resigned from the Board ... a Principal at SAIF Partners, a leading growth capital fund ...
... CHAPEL HILL, N.C., May 31, 2011 Cempra Pharmaceuticals ... executive officer, will present at the Jefferies 2011 Global ... at the Grand Hyatt in New York City.  Dr. ... leading antibiotic clinical programs, solithromycin for community-acquired bacterial pneumonia ...
Cached Medicine Technology:Sinovac Appoints Kenneth Lee to Board of Directors 2
(Date:5/5/2015)... The 2015 Crystal Ball, hosted by the Hepatitis ... outreach and patient advocacy programs. The gala evening included dancing, ... hundreds of supporters. , The 2015 gala was dedicated to ... virus (HBV) by Dr. Baruch S. Blumberg, who passed away ... for his discovery of the virus in 1976. He and ...
(Date:5/5/2015)... Jacksonville, Fla. (PRWEB) May 05, 2015 ... from the Commission on Cancer (CoC) of the American ... a cancer program must meet more than 30 Commission ... years through a survey process, and maintain levels of ... , When patients choose to seek care locally ...
(Date:5/5/2015)... " QuickPick Travel ” was featured on NewsWatch ... look small, medium, and large businesses making an impact in ... business expert, conducted the business review and shared with viewers ... three weeks of vacation for free. , Vacations are a ... the world. And when people are preparing for vacations, they’re ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 ... Platform that enables businesses to deploy Mobile Engagement Campaigns ... Constant Contact . ProTexting clients can now leverage the ... reach by collecting and syncing subscribers’ e-mail addresses into ... says “We have recognized that the growing trend of ...
(Date:5/5/2015)... Orange, New Jersey (PRWEB) May 05, 2015 ... system, today announced the launch of a new healthy ... Talbot, a season two semi-finalist on Bravo’s Top Chef, ... dishes that promote wellness and healthy living. In ... an enhanced Wellness Website and the videos will be ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 2Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 3
... Designed to Reduce the Risk of a Subsequent Stroke, ... today,announced the launch of The TIA (Transient Ischemic Attack) ... the first of its kind in,Central Texas -- in ... stroke after TIA., A TIA is a "warning ...
... NET SatisFAXtion recognized for highly reliable and secure VoIP fax solutions ... ... (Vocus) October 27, 2008 -- FaxBack® , the leading provider ... INTERNET TELEPHONY® Magazine - the VoIP authority since 1998 - has ...
... - Special Needs Plan focuses on added benefits ... for Medicare beneficiaries with chronic health conditions -, ... the upcoming,Medicare annual enrollment period which begins November ... its 2009 Special Needs Plan,(SNP) offerings for chronically ...
... to $4.7 million in the ... revenue of $4.3 million in the first quarter of fiscal 2009, a 26% ... year-over-year increase, - Strong sales to pharmaceutical manufacturers and retail market customers ... drove growth in the first quarter - ...
... Dietitian Kris Clark, Ph.D., offers easy tips ... and fun - Halloween!, WASHINGTON, Oct. 27 If ... aged five to thirteen years, are,poised to don costumes to ... on sweet treats, registered dietitian Kris Clark,Ph.D., of Pennsylvania State ...
... Business Impact for the development of an automated process to dramatically ... , ... Irvine, CA (Vocus) October 27, 2008 -- When ... , , ,LifeMasters Supported SelfCare, Inc. is strengthening its health improvement ...
Cached Medicine News:Health News:St. David's HealthCare Launches The TIA Center for Stroke Prevention at St. David's Medical Center 2Health News:St. David's HealthCare Launches The TIA Center for Stroke Prevention at St. David's Medical Center 3Health News:FaxBack Wins the 2008 Internet Telephony Excellence Award 2Health News:FaxBack Wins the 2008 Internet Telephony Excellence Award 3Health News:Care Improvement Plus Launches 2009 Benefits in Georgia 2Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 2Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 3Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 4Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 5Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 6Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 7Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 8Health News:No Trick to Halloween Sweet Treats 2Health News:No Trick to Halloween Sweet Treats 3Health News:LifeMasters Receives 2008 Vision Award for Business Impact 2Health News:LifeMasters Receives 2008 Vision Award for Business Impact 3
For the quantitative in vitro determination of Aspartate Aminotransferase (AST) in serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
Medicine Products: